Palliative care can help alleviate the suffering and symptoms that go along with serious disease, making it an important component when caring for complex, high-need patients, said Allison Silvers, vice president of payment and policy at the Center to Advance Palliative Care.
Palliative care can help alleviate the suffering and symptoms that go along with serious disease, making it an important component when caring for complex, high-need patients, said Allison Silvers, vice president of payment and policy at the Center to Advance Palliative Care.
Transcript (slightly modified)
Why is it important to increase access to palliative care for complex and high need patients?
Well, that’s an easy question. I think every complex, high-need, seriously ill patient should have palliative care. What palliative care really boils down to is relieving any suffering that goes along with having that complex or serious need, so it should be part and parcel. There’s pain that goes along with a lot of conditions, there’s a variety of other symptoms, there’s functional impairment, so even with things like COPD, you suddenly become limited in what you can do, maybe not so suddenly sometimes, there’s obviously a lot of gradual deterioration in populations as well.
But there are ways to relieve the pain, the symptoms, to get support for the places where you need support. So I think palliative care needs to be just completely integrated into the care of seriously ill and complex populations.
Impact of Amivantamab-Lazertinib on EGFR, MET Resistance Alterations in NSCLC: Danny Nguyen, MD
September 15th 2025The combination of amivantamab and lazertinib in first-line non–small cell lung cancer (NSCLC) significantly reduces resistance mechanisms with implications for second-line treatment, said Danny Nguyen, MD, of City of Hope.
Read More
Disparities in Biomarker Testing Impact Nonsquamous NSCLC Outcomes: Surbhi Singhal, MD
September 6th 2025Surbhi Singhal, MD, of the University of California Davis, discussed disparities in biomarker testing among patients diagnosed with stage IV nonsquamous non–small cell lung cancer (NSCLC).
Read More
Rurality, Long Travel Times Limit Access to Tobacco Treatment for Patients With COPD Who Smoke
August 30th 2025Patients with chronic obstructive pulmonary disease (COPD) who smoke were less likely to receive tobacco dependence treatment (TDT) if they lived in rural areas or had longer travel times to care, highlighting persistent geographic disparities in access.
Read More